Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 2013; 20(4): 305-308


The Prevalence of Thyroid Cancers in Endemic Goitre Patients in Bingöl City

Özlem Üçer

 

.




Abstract


Objective: Thyroid cancer is the most common malignancy of the endocrine organs, and it accounts for 1% of all cancers. Its incidence increases in sites of endemic iodine deficiency and goiter. The aim of this study is to investigate the thyroid cancer incidence and types in nodular goiter cases operated in the city of Bingol, which is an iodine deficiency region.

Material and Methods: The pathology reports of thyroid surgical materials which were sent to Bingöl Government Hospital pathology department were screened retrospectively from the archives between the years 2004-2012. Postoperative histopathologic examinations of 1275 cases that received nodular goiters diagnosis were evaluated in 8 years.

Results: 1130 (88.6%) of 1275 cases female and 145 (11.4%) were male. The youngest patient was 13 and the oldest patient was 85 years old and the average age is 42,7±11,4. Histopathological examination of 1073 (84.2%) cases of nodular hyperplasia, 12 (0.9%) cases of diffuse hyperplasia, 57 (4.5%) cases of lymphocytic thyroiditis, 133 (10.4%) patients had thyroid tumors. The 133 tumors on the 33 (25%) cases benign, 100 (75%) cases were malign. As a type of cancer 88 (66.1%) cases papillary carcinoma, 11 (8.2%) cases follicular carcinoma, 1 (0.7%) case were medullary carcinoma.

Conclusions: Iodine deficiency area in the province of Bingöl in patients with nodular goiter who underwent surgery for thyroid cancer rate of 7.8% and most cancers is seen as a type of thyroid papillary carcinoma.

Key Words: Goiter; Iodine Deficiency; Thyroid Cancer.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.